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Objective: The cognitive-constructivist psychotherapy approach considers the self
as a continuous regulation process between present and past experience, in which
attributions of meaning is characterized by the use of internal rules. In this conception,
everyone would be driven by a specific inner coherence called Personal Meaning
Organization (PMO). Such approach has never been applied to neurological patients
by means of ad hoc developed tools. We performed an explorative study aimed to
characterize personality styles in different neurological conditions within the theoretical
framework of cognitive-constructivist model.
Materials and Methods: Three groups of neurological patients (Amyotrophic Lateral
Sclerosis, Multiple Sclerosis, Primary Headache) and a sample of healthy participants,
each composed by 15 participants, for a total of 60 participants, were recruited.
The Personal Meaning Questionnaire (PMQ), an Italian questionnaire assessing PMOs
construct, and other clinical tools for psychological and quality of life assessment were
administered to all subjects.
Results: The main finding concerned the detection, across all clinical conditions, of
a higher prevalence of phobic personality style, with Amyotrophic Lateral Sclerosis
showing a relevant prevalence of such PMO with respect to all other neurological
conditions and controls. However, with respect to controls, in all clinical conditions,
PMQ highlighted a tendency, even if not statistically significant, to codify experience by
means of specific cognitive and emotional patterns.
Conclusion: Our findings represent the first contribution towards understanding
the personality profiles of patients affected by neurological conditions according to
cognitive-constructivist theory.
Keywords: Amyotrophic Lateral Sclerosis, cognitive-constructivist psychotherapy, multiple sclerosis, personality,
personal meaning questionnaire, primary headache
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INTRODUCTION
Within the theoretical background of cognitive-constructivism,
the introduction of concepts such as ‘cognitive organization’
and ‘personal meaning organization’ (PMO) provided a general
and explanatory theory of personality (Guidano, 1981, 1987;
Guidano and Liotti, 1983). Psychotherapy based on cognitive-
constructivist approach considers the self as a continuous
regulation process between past and present experience, where
the attribution of meaning is based on individual rules aimed
to maintain internal consistency, in a dynamic dialectic between
immediate experience (implicit) and the reorganization of such
experience (explicit), as well as to manage perturbations arising
from the environment. According to such theory, everyone
is oriented by an internal consistency provided by ‘personal
meaning organization styles’. Four PMOs have been described:
depressive, phobic, eating disorder and obsessive (Guidano, 1981,
1987). In the latest elaborations of this theory, such organizations
are represented as ‘personality styles’ which can be observed
also in non-clinical populations (Arciero, 2002; Picardi et al.,
2003).
The Eating Disorder Organization (ED) identifies individuals
who tend to select internal states and opinions based on an
external point of reference; they are thus characterized by a strong
attention to expectations perceived in others, a need for approval,
a sensitivity to judgment and to criticism.
The Obsessive Organization (OBS) identify individuals where
the sense of self is based primarily upon conscious control
of behavior and thinking, both of which are expected to
match abstract principles; they present themes of responsibility,
anticipatory control, equity, order, certainty and coherence.
The Phobic Organization (PHOB) is characterized by a
vulnerable sense of self that interprets emotional states as
impediments to action. Such individuals are characterized by
themes of freedom and invincibility commonly entangled with
those of health, friendship, affective stability.
The Depressive Organization (DEP) is characterized by a
sense of personal ineptitude on the affective level and a
constant experience of solitude within one’s primary attachment.
A tendency to perceive a continuous and latent sense of loss in
life events can be observed in such individuals.
The development by Picardi and Mannino (2001), Picardi
(2003), and Picardi et al. (2003) of the Personal Meaning
Questionnaire (PMQ), aimed at assessing the construct of
PMO, provided new methods of investigation within cognitive-
constructivist paradigm. A successive experimental study
(Picardi et al., 2004) further supported the convergent validity of
such tool against other widely used personality questionnaires,
such as the Temperament and Character Inventory (TCI-125;
Cloninger et al., 1994) and the Big Five Questionnaire (BFQ;
Caprara et al., 1993). Moreover, it has also been employed in
order to highlight associations between different personality
styles and cognitive evaluation of emotional stimuli in healthy
subjects, by means of functional magnetic resonance imaging -
fMRI (Bertolino et al., 2005; Rubino et al., 2007). However, such
instrument has never been administered to patients affected by
neurological diseases.
In the past, several authors investigated personality styles in
neurological disease in order to identify the possible influence
of permanent emotional and psychological aspects on disease
onset, course and management (Aben et al., 2002; Bragazzi,
2013). However, less attention has been paid to the identification
of specific personality profiles characterizing patients with
neurological diseases. Within this field, studies focused on
patients with chronic and disabling disease, such as Parkinson’s
disease and Multiple Sclerosis (MS), as well as patients
suffering from chronic pain, such as headache and migraine.
Fewer findings, even if promising, concern another disabling
neurological condition, that is Amyotrophic Lateral Sclerosis
(ALS), where a complex interplay between cognitive, emotional
and neurobiological aspects has been recently highlighted
(Goldstein and Abrahams, 2013).
Amyotrophic Lateral Sclerosis can be defined as a
neurodegenerative disorder characterized by progressive
muscular paralysis reflecting degeneration of motor neurons
(MNs) in the primary motor cortex, brainstem, and spinal
cord (Silani et al., 2011). Cognitive impairment occurs in
approximately 30% of ALS patients with about 10% of patients
presenting frontotemporal dementia, mostly the behavioral
variant (Beeldman et al., 2015).
Clinical manifestations of MS are much more variable, both
concerning onset features and progression. MS is a disease of the
central nervous system, which affects the brain, spinal cord, and
the optic nerves. Four different MS subtypes have been identified
and defined: relapsing-remitting (RRMS), secondary-progressive
(SPMS), primary-progressive (PPMS), and progressive-relapsing
(PRMS) (Lublin and Reingold, 1996). Afterward the clinical
isolated syndrome (CIS), MS with benign course and MS
with malign course forms have been recognized (Trojano and
Paolicelli, 2001; Polman et al., 2011; Lublin et al., 2014).
The Primary Headache (PH) syndrome, frequently observed
in clinical practice, could manifest as migraine, tension headache
or cluster headaches, with episodic or chronic course (Headache
Classification Committee of the International Headache Society,
1988, 2004).
The association between MS, headache and ALS and
specific psychological disorders has been discussed for a
long time, but only in the last decades systematic studies
have been performed in order to better define these aspects.
In MS, psychological problems are often described as a
specific consequence of adaptation to physical and sensory
impairments related to the chronic and progressively disabling
disease (Baretz and Stephenson, 1981; Johansson et al., 2016).
Some authors, however, reported that such emotional aspects
cannot be closely correlated with the diagnosis (Withlock
and Siskind, 1980), highlighting the presence of independent
characteristics contributing to them. The most frequently
described psychological disorder in MS is depression, with a
prevalence rate of 50% reported after diagnosis (Sadovnick
et al., 1991; Feinstein, 2011). The incidence of this disorder in
MS is significantly increased both compared to other chronic
diseases (Minden et al., 1987; Patten et al., 2003; Even et al.,
2004) and to other neurological conditions (Rabins et al., 1986).
A biologic hypothesis suggests that onset of depression in
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MS may be induced by temporal regions lesions secondary to
the disease (Mohr et al., 2003). Besides, also specific anxiety
disorders have been described in MS patients (Korostil and
Feinstein, 2007). Similarly to MS, also headache appears to be
closely correlated with depressive symptoms, particularly when
disease becomes chronic causing feelings of inadequacy, negative
thinking, diminished interest for environment and relationships,
affecting patients’ quality of life – QoL (Blomkvist et al., 2002;
Manack et al., 2011). In the last decade, however, it has been
suggested that depressive and anxious features, as well as other
psychological aspects, may be a distinctive characteristic of this
population of patients, instead of a consequence of experimenting
chronic pain (Mongini et al., 2000; Torelli et al., 2008; Berry
and Drummond, 2014; Bottiroli et al., 2016; Muñoz et al., 2016).
In ALS population, by contrast, Major Depressive Disorder
(MDD) seems to be an uncommon result, with a prevalence
similar to that of the adult general population (Norris et al.,
2010). Of greater importance appears to be the tendency of
ALS patients to actively negate the disease, so relegating it out
of conscious awareness (Brown and Mueller, 1970; Grossman
et al., 2006). In ALS, the so-called ‘disability paradox’ concerns
evidence that subjective QoL and emotional well-being in
ALS patients are comparatively good and partially unrelated
to physical functioning and disease severity and progression
(Kurt et al., 2007; Lulé et al., 2008, 2012; Norris et al.,
2010).
The possible existence of a specific personality profile for
these three diseases has been suggested. In particular, personality
aspects have been depicted in MS, according to several studies
(Invernizzi et al., 1988; Merkelbach et al., 2003; Fishman et al.,
2004; Incerti et al., 2015; Schreiber et al., 2015; Mohamadi
et al., 2016; Strober, 2016; Zarbo et al., 2016), even if some of
them focused only on euphoric symptoms and emotional lability
(Feinstein, 2004). Moreover, recent findings suggest a possible
role of personality even in clinical neuroscience of MS (Benedict
et al., 2013).
Patients with migraine have been described as having
particular difficulties in recognition of their own emotions,
showing high levels of anxiety and frequent concerns about
their health (Yucel et al., 2002; Norton and Asmundson, 2004),
suggesting such features as distinctive patients’ characteristics
(Torelli et al., 2008; Berry and Drummond, 2014).
Concerning ALS, even if some studies suggested the presence
of a specific personality style characterizing such patients (Brown
and Mueller, 1970; Grossman et al., 2006), some others were
unable to support such findings (Houpt et al., 1977; Peters et al.,
1978). Such conflicting literature still remains a unresolved issue.
To assess personality profiles, different tools have been
employed in the past in MS, ALS, and PH diseases. Between
them, it is worthwhile mentioning: Temperament and Character
Inventory (TCI, Abbate-Daga et al., 2007; Fazekas et al., 2013;
Verdolini et al., 2015), Neo Personality Inventory (NEO-PI;
Krampe et al., 2008; Berry and Drummond, 2014; Incerti
et al., 2015), Millon Clinical Multiaxial Inventory III (MCMI-
III; Mohamadi et al., 2016), Eyesenk Personality Questionnaire
(EPQ; Aaseth et al., 2011), and the Iowa Scale of Personality
Change (ISPC; Waldron et al., 2014).
Moreover, a widely used personality inventory, the Minnesota
Multiphasic Personality Inventory (MMPI; Hathaway and
McKinley, 1997) has also been employed in such neurological
populations highlighting a specific bias in ALS and MS
patients, where personality profile appears to be influenced by
an overestimation of the ‘psychosomatic’ profile due to the
specific content of some items. Accordingly, some authors had
discussed the opportunity to use an ad hoc statistical correction
for neurological patients in order to balance disease related
symptoms influence on personality description (Nelson et al.,
2003; Incerti et al., 2016).
Overall, despite different tools have been used, no conclusive
data were obtained concerning the role of personality in the above
mentioned neurological diseases, especially when considering the
existence of a disease specific personality profile.
The use of PMQ, and the underlying cognitive-constructivist
model, aims to take into account the complexity of human
experience and not only specific personality dimensions; it
demonstrated to be independent from changes across time
in levels of depression and anxiety and to have a strong
convergent validity with other traditional personality inventories
(Picardi et al., 2004). For these reasons, it can be considered
as a useful and comprehensive measure to be employed with
neurological patients. By means of PMQ, the present study aims
to explore personality features of neurological patients with ALS,
MS, or PH in order to possibly identify specific personality
profiles characterizing such conditions within the cognitive-
constructivist frame. The study of these three clinical populations
could provide suggestions on factors influencing chronic
or degenerative neurological disorder subjective experience.
According to psychological and quality of life components
involved in chronic neurological diseases, also such dimensions
together with personality were explored. Such investigation could
possibly deeply characterize clinical samples, thus better defining
disease-specific psychological features from a comprehensive
perspective.
MATERIALS AND METHODS
Subjects
Three different groups of patients were recruited: 15 patients with
ALS, 11 with spinal onset, and 4 with bulbar onset (5 females;
mean age: 60.0+ 10.3 years old; mean education 9.0+ 3.6 years);
15 patients with RRMS (11 females; mean age 41.3 + 7.0 years
old; mean education 12.3 + 3.2 years); 15 patients with PH,
of which 5 with tension-type headache, 2 with migraine, and 8
with mixed headache (10 females; mean age 36.1 + 15.0 years
old; mean education 12.7 + 4.0 years old). Diagnosis of possible
or probable ALS and MS was made according to El Escorial
(Brooks et al., 2000) and McDonald (McDonald et al., 2001)
criteria, respectively. Patients suffering from PH were diagnosed
according to ICDH criteria (Headache Classification Committee
of the International Headache Society, 1988).
Control group was composed by 15 healthy participants
(9 females, mean age 42.3 + 12.0 years old; mean education
12.5 + 2.3 years old), not affected by any chronic clinical
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condition or suffering from any psychiatric or neurological
disorder.
The study protocol was approved by the Ethics Committee
of IRCCS Istituto Auxologico Italiano and all eligible subjects
received verbal and written information about the study. All
participants signed an informed consent, according to the
Declaration of Helsinki.
Psychological and Personality
Assessment
Each subject underwent a battery of measures investigating
psychological, QoL and personality features: The Personal
Meaning Questionnaire (PMQ), the State-Trait Anxiety
Inventory – Form Y (STAI-Y), the Beck Depression Inventory
(BDI), the Symptom Check List 90 (SCL-90), and the Short-Form
Health Survey 36 (SF-36).
PMQ consists of a self-report questionnaire, developed by
Picardi and Mannino (2001), Picardi (2003), and Picardi et al.
(2003), aimed at empirically support the validity of the ‘personal
meaning organizations’ theory developed by Guidano (Guidano,
1987). Such tool intends to explore thoughts, feelings and
behaviors as expected in the different PMOs. It is composed
by 68 items, to be answered according to the level of
agreement/disagreement or to a 5-points Likert scale.
The State-Trait Anxiety Inventory-Y (STAI-Y) (Spielberger
et al., 1989) is aimed at detecting and evaluating anxiety
symptoms, concerning both state (STAI-Y1) and trait (STAI-Y2)
anxiety components. It is made of 40 questions, to be answered
according to both intensity and frequency of symptoms.
The BDI (Beck et al., 1979) evaluates depressive
symptomatology, concerning somatic, emotional, cognitive
and motivational components. It is composed by 21 items, each
of them corresponding to a symptoms cluster useful to identify
severity of depression.
SCL-90 inventory (Derogatis et al., 1973) was employed
in order to evaluate a broad range of psychopathological
symptoms. Such scale contains 90 items, highlighting mental
disease according to 9 symptoms dimensions that correspond to:
somatization (SOM), obsessive–compulsive (O–C), interpersonal
sensitivity (IS), depression (DEP), anxiety (ANX), hostility
(HOS), phobic anxiety (PHOB), paranoid ideation (PAR), and
psychoticism (PSY). A further questionnaire, the SF-36 (Apolone
et al., 1997), was also administered in order to detect health
related QoL, consisting of a multidimensional tool made of 36
questions. Items concern 8 different health domains: physical
functioning (PF), role limitations due to physical health (RP),
bodily pain (BP), general health (GH), energy (EN), social
functioning (SF), role limitations due to emotional problems
(RE), mental health (MH). The SF-36 has eight scaled scores;
the scores are weighted sums of the questions in each section.
Scores range from 0 to 100, with lower scores suggesting more
disability.
Statistical Analysis
Descriptive data are reported as means ± standard deviations
for continuous variable and as absolute numbers for categorical
variable. Distribution of the variables in terms of proximity to
normal was detected by Shapiro-Wilk test; the homogeneity of
variances was performed with Bartlett test. For the variables
normally distributed and homoscedastic, the ANOVA with
pairwise t-test as post hoc was used; otherwise a Kruskal–
Wallis rank sum test was employed with pairwise Wilcoxon
rank sum test as post hoc. For multiple comparisons, the
algorithm which controls the expected rate of false-positive
results for all positive results (false discovery rate) was
used. For each individual the QSP profile was calculated
using the maximum values among the following variables:
ED, DEP, PHOB, and OBS. The QSP prevalence was tested
using the Fisher exact test. Finally, a Spearman’s rank
correlation analysis (rs) was employed to examine relationships
between scores obtained at the different questionnaires. An
α level of 0.05 was used for all hypothesis tests. All data
analyses were performed using R Core Team (2015), Vienna,
Austria.
RESULTS
Characteristics of Subjects
See Table 1 for descriptive statistics concerning psychological,
QoL, and personality features of neurological patients and
controls.
Multiple Sclerosis and PH groups are comparable according
to age, both within them and when compared to controls.
Differently, ALS group significantly differs from the other three
groups with regard to age (p < 0.01); this data is in accordance
with late onset of ALS when compared to MS and PH patients.
When considering educational level, MS and PH patients
are comparable among them and with the control sample. ALS
patients have a significantly lower level of education with respect
to controls (p = 0.029), and both MS (p = 0.037) and PH
(p= 0.037) groups.
Psychological and QoL Features
The comparison between the three neurological populations and
the control sample highlights a global condition of psychological
stress in the former, with prominent anxiety components
depicted. In fact, significant anxiety symptoms where observed in
all the three neurological conditions, and more specifically with
regard to MS (STAI-Y1: p = 0.027, STAI-Y2: p = 0.001, SCL-90
ANX: p = 0.008), PH (STAI-Y1: p = 0.004, STAI-Y2: p = 0.003,
SCL-90 ANX: p= 0.006) and ALS (STAI-Y1: p= 0.004, STAI-Y2:
p= 0.021, SCL-90 ANX: p= 0.010) groups.
Thoughts are consistently focused on the clinical condition
(SCL-90 PHOB: MS, p = 0.037; PH, p = 0.036; ALS, p < 0.001)
and patients seem to present recurring ruminations about health-
related issues (SCL-90 O–C: MS, p = 0.019; PH, p = 0.019; ALS,
p= 0.019).
Moreover, a significant reduction in social activities is
observed in PH and ALS (SF-36 SF: PH, p < 0.001; ALS,
p = 0.008). Higher rates of psychoticism are reported by all
neurological samples (SCL-90 PSY: MS, p= 0.009; PH, p= 0.009;
ALS, p= 0.009). Somatic expression of the underlying emotional
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TABLE 1 | Mean (standard deviation, SD) scores obtained by neurological patients and control subjects at psychological questionnaires.
MS PH ALS CONTROL p-value
STAI-Y1 42.67 (14.95)∗ 46.60 (13.94)∗∗ 46.87 (13.22)∗∗ 30.93 (6.62) 0.003
STAI-Y2 46.73 (12.87)∗∗ 44.53 (12.01)∗∗ 41.40 (10.91)∗ 30.87 (6.99) 0.001
BDI 12.47 (10.70)∗∗ 14.40 (13.78)∗∗ 16.20 (9.37)∗∗∗ 2.67 (2.35) < 0.001
SF-36 PF 72.00 (23.89) 84.67 (18.27) 37.00 (29.20)∗∗∗ 90.33 (10.60) < 0.001
SF-36 RP 41.67 (41.90)∗∗∗ 40.00 (38.73)∗∗∗ 35.00 (40.97)∗∗∗ 98.33 (6.45) < 0.001
SF-36 BP 58.73 (28.07)∗ 36.07 (23.19)∗∗∗ 61.40 (26.79)∗ 83.53 (19.84) < 0.001
SF-36 GH 42.67 (24.63)∗∗∗ 56.20 (14.84)∗ 38.40 (24.31)∗∗∗ 76.67 (11.78) < 0.001
SF-36 EN 50.67 (22.82) 43.00 (23.05) 52.33 (24.92) 64.33 (15.80) 0.075
SF-36 SF 68.53 (30.13) 51.40 (20.95)∗∗∗ 61.93 (25.62)∗∗ 88.53 (13.61) 0.001
SF-36 RE 53.40 (43.32)∗∗ 42.27 (44.53)∗∗ 48.87 (43.45)∗∗ 93.40 (13.67) 0.004
SF-36 MH 58.53 (19.46)∗∗ 52.00 (25.12)∗∗ 59.20 (22.94)∗ 79.73 (12.78) 0.002
SCL-90 SOM 14.67 (9.36)∗∗ 17.53 (10.79)∗∗ 12.00 (9.20)∗∗ 4.87 (4.31) 0.002
SCL-90 O-C 11.40 (9.26)∗ 12.73 (8.84)∗ 6.87 (4.49)∗ 3.33 (3.54) 0.006
SCL-90 IS 7.07 (4.53) 8.20 (8.40) 5.60 (5.21) 2.93 (3.83) 0.043
SCL-90 DEP 14.73 (11.73)∗∗ 14.40 (11.93)∗∗ 12.47 (11.20)∗∗∗ 2.93 (2.81) < 0.001
SCL-90 ANX 9.20 (7.02)∗∗ 10.20 (9.00)∗∗ 6.60 (6.66)∗ 2.00 (2.59) 0.002
SCL-90 HOS 4.80 (3.75)∗∗ 4.93 (5.04)∗∗ 2.67 (1.95)∗ 0.87 (0.99) < 0.001
SCL-90 PHOB 1.73 (2.15)∗ 2.87 (3.38)∗ 3.53 (5.329∗∗∗ 0.27 (0.59) 0.002
SCL-90 PAR 4.40 (2.59) 6.60 (6.44) 3.27 (2.28) 2.20 (2.93) 0.056
SCL-90 PSY 5.87 (6.15)∗∗ 7.33 (7.88)∗∗ 4.00 (2.42)∗∗ 1.33 (2.23) 0.004
PMQ ED 51.40 (11.67)∗ 53.93 (12.70)∗ 49.47 (11.79) 40.80 (11.89) 0.022
PMQ DEP 43.13 (10.67)∗ 44.07 (14.32)∗ 40.60 (8.25) 32.80 (9.06) 0.025
PMQ PHOB 58.33 (8.37) 64.00 (9.07) 65.00 (7.46)∗ 56.87 (7.56) 0.017
PMQ OBS 55.07 (8.75) 59.60 (9.77) 56.53 (7.30) 53.87 (8.15) 0.297
∗p < 0.05; ∗∗p < 0.01; ∗∗∗p < 0.001.
STAI-Y1, State Anxiety Inventory-Form Y; STAI-Y2, Trait Anxiety Inventory – Form Y; BDI, Beck Depression Scale; SF-36, Short-Form Health Survey 36; SF-36 PF, physical
functioning; SF-36 RP, role limitations due to physical health; SF-36 BP, bodily pain; SF-36 GH, general health; SF-36 EN, energy; SF-36 SF, social functioning; SF-36
RE, role limitations due to emotional problems; SF-36 MH, mental health; SCL-90, Symptom Check List 90; SCL-90 SOM, somatization; SCL-90 O–C, obsessive–
compulsive; SCL-90 IS, interpersonal sensitivity; SCL-90 DEP, depression; SCL-90 ANX, anxiety; SCL-90 HOS, hostility; SCL-90 PHOB, phobic anxiety; SCL-90 PAR,
paranoid ideation; SCL-90 PSY, psychoticism; PMQ, Personal Meaning Questionnaire; PMQ ED, Eating Disorder personal meaning organization; PMQ DEP, Depressive
personal meaning organization; PMQ PHOB, Phobic personal meaning organization; PMQ OBS, Obsessive personal meaning organization.
diseases have been reported globally in neurological patients
(SCL-90 SOM: MS, p= 0.009; PH, p= 0.009; ALS, p= 0.009).
Mood of patients, when compared to controls, is globally
depressed, with feeling of sadness and substantial pessimism
about future (SCL-90 DEP: MS, p = 0.004; PH, p = 0.005;
ALS, p < 0.001; BDI: MS, p = 0.003; PH, p = 0.009; ALS,
p< 0.001). Moreover, feeling of anger and other-directed hostility
are present in all conditions (SCL-90 HOS: MS, p = 0.002; PH,
p= 0.002; ALS, p= 0.01) (See Figure 1).
As expected, neurological samples show a lower QoL when
compared to control group, even if a prevalence of bodily over
emotional component has not been recorded (see Figure 2).
In particular, patients rate their health related condition as
less satisfying than controls (SF-36 GH: MS, p < 0.001; PH,
p = 0.013; ALS, p < 0.001), with role limitations due to physical
and emotional problems in all three conditions (SF-36 RP: MS,
p = < 0.001; PH, p < 0.001; ALS, p < 0.001; SF-36 RE: MS,
p= 0.009; PH, p= 0.007; ALS, p= 0.009). Moreover, a substantial
dissatisfaction concerning MH is highlighted (SF-36 MH: MS,
p= 0.005; PH, p= 0.005; ALS, p= 0.017). Limitations in physical
activities are reported by all patients (SF-36 PP: MS, p= 0.03, PH,
p< 0.001, ALS, p= 0.03). In PH group, a tendency to a reduction
in energy and vitality is reported (SF-36 EN: p= 0.06).
When comparing the three neurological conditions, different
rates of satisfaction with regard to global health-related status
are observed, with lower levels reported for ALS with respect to
PH (SF-36 GH: PH > ALS, p = 0.025). Another relevant result
concerns BP, that is rated as more disabling by PH patients (SF-36
BP: PH>ALS: p= 0.02; PH>MS: p= 0.02; PH vs N, p≤ 0.001),
even if also reported by both ALS and MS (SF-36 BP: ALS > N,
p= 0.03; MS > N, p= 0.03).
Correlations
With regard to controls, correlations concerning relationships
between PMQ and other measures showed that in the ED PMO
thoughts are characterized by a strong sensitivity to judgment
perceived in others (SCL-90 PAR: rs = 0.618, p = 0.014; SCL-
90 O-C: rs = 0.765, p = 0.001). This aspect is accompanied by a
reduction of engagement in social activities and increased feelings
of personal inadequacy and inferiority in comparisons with
others (SF-36 SF: rs = –0.599, p = 0.018; SCL-90 IS rs = 0.560,
p = 0.026). Several correlations are also present with distress
arising from bodily perceptions (SCL-90 SOM: rs = 0.596,
p = 0.019), increased levels of anxiety or depression (BDI:
rs = 0.608, p = 0.016; SCL-90 DEP: rs = 0.678, p = 0.006; STAI
Y2: rs = 0.705, p = 0.003; SCL-90 ANX: rs = 0.730, p = 0.002)
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FIGURE 1 | Mean scores at SCL-90 subscales in the patients groups (ALS, MS, PH) and control subjects. SCL-90, Symptom Check List 90; SOM,
somatization; O–C, obsessive–compulsive; IS, interpersonal sensitivity; DEP, depression; ANX, anxiety; HOS, hostility; PHOB, phobic anxiety; PAR, paranoid
ideation; PSY, psychoticism.
and reduction in motor initiative (SF-36 PF: rs = –0.801,
p= 0.000).
In the neurological samples, ED PMO presents with different
features with respect to controls. In ALS, higher rates of
avoidance behaviors and concerns about their own MH are
reported (SCL-90 PHOB: rs = 0.571, p = 0.026; SF-36 MH:
rs = –0.517, p= 0.049), while in MS a reduction in energy/vitality
is revealed (SF-36 EN: rs = –0.572, p = 0.026). Similarly, in PH
a higher destabilization is observed with respect to controls, with
higher levels of withdrawal and isolation from others and lower
perceived MH with respect to controls (SF-36 MH: rs = –0.588,
p= 0.021; SCL-90 PSY: rs = –0.667, p= 0.007).
In the control group, the DEP PMO is associated by depressive
symptoms with signs of withdrawal from interests, lack of
motivation and loss of vital energy, together with isolations (BDI:
rs = 0.542, p = 0.037; SCL-90 DEP: rs = 0.571, p = 0.026; SCL-
90 PSY: rs = 0.533, p = 0.033). Those findings seem to influence
also GH status and engagement in physical activities (SF-36 PF:
rs = –0.707, p= 0.003; SF-36 GH: rs = –0.573, p= 0.025).
Such aspects are observed also in MS and PH populations;
in particular, in the DEP PMO the presence of a neurological
disease seems to further reduce interest for environment and
social relations (SF-36 SF: MS, rs = –0.726, p = 0.002; SCL-90
PHOB: rs = 0.574, p= 0.025; SCL-90 IS: MS and PH, rs ≤ 0.767,
p ≤ 0.007). Thoughts appear characterized by more severe
worries (SCL-90 PAR: rs ≤ 0.649, p ≤ 0.023; SCL-90 O-C:
rs ≤ 0.648, p = 0.016), mainly concerning physical symptoms in
MS (SF-36 BP: rs = –0.519, p = 0.047; SCL-90 SOM: rs = 0.566,
p = 0.028) and mental health in PH (SF-36 MH: rs = –0.588,
p = 0.021). These concerns are accompanied by relevant anxiety
in such patients (STAI Y2: rs ≤ 0.712, p ≤ 0.025; SCL-90 ANX:
rs ≤ 0.578, p ≤ 0.031).
Differently, in ALS subgroup no significant correlations have
been observed between PMQ and other questionnaires.
The PHOB PMO in the control group reveals a mindset
characterized by distinct concerns for health status and
limitations that could arise from emotional disturbances (SF-36
GH: rs = –0.589, p = 0.021; SF-36 RE: rs = –0.561, p = 0.029).
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FIGURE 2 | Mean scores at SF-36 subscales in the patients groups (ALS, MS, PH) and control subjects. SF-36, Short-Form Health Survey 36; PF, physical
functioning; RP, role limitations due to physical health; BP, bodily pain; GH, general health; EN, energy; SF, social functioning; RE, role limitations due to emotional
problems; MH, mental health.
Patients with such PMO presenting with ALS manifest increased
generalized anxiety symptoms (STAI Y1: rs = 0.537, p = 0.039),
while PH patients reveal withdrawal and isolation (SCL-90 PSY:
rs = 0.689, p = 0.005). Both these neurological conditions, share
the presence of more frequent concerns that may turn into
ruminations (SCL-90 O-C: rs ≤ 0.541, p ≤ 0.043). Conversely,
no correlations have been observed between psychological
symptoms in MS and PHOB organization of personality.
No correlations between physical and psychological
symptoms and OBS PMO were detected in all groups considered.
Personal Meaning Questionnaire
Personal Meaning Questionnaire data analysis in MS patients
showed higher values of ED (p = 0.025) and DEP organizations
(p = 0.034) when compared to control sample. Similarly, in
PH subgroup higher values of ED (p = 0.025) and DEP
(p = 0.034) organizations were observed. Finally, ALS subgroup
showed higher rates of PHOB (p = 0.050) with respect to
controls.
Across all the four conditions, a higher prevalence of PHOB
organization has been detected, without significant differences
between groups (MS: 66.67%, PH: 80%, ALS: 93.33%, controls:
60%; p= 0.14) (see Figure 3).
DISCUSSION
For a long time, personality of neurological patients has been
poorly investigated, as well as psychotherapeutic approaches
tailored on these populations.
The present study has been aimed to empirically investigate
the construct of personal meaning organization developed by
Guidano (Guidano, 1987), by employing the PMQ for evaluating
three different groups of patients with neurological disease (ALS,
MS, PH). In particular, the study aimed to explore, with a specific
tool designed for detecting PMO styles, the possible presence
of peculiar personality features characterizing the neurological
conditions examined.
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FIGURE 3 | Distribution of PMO in the three neurological conditions
and in control subjects. PMQ, Personal Meaning Questionnaire; ED, Eating
Disorder personal meaning organization; DEP, Depressive personal meaning
organization; PHOB, Phobic personal meaning organization; OBS, Obsessive
personal meaning organization.
The main finding concerns the detection, across all clinical
conditions, of a higher prevalence of PHOB personality style, with
ALS showing a relevant prevalence of such PMO with respect to
all other neurological conditions and controls.
However, with respect to controls, in all clinical conditions,
PMQ highlighted a tendency to codify experience by means of
specific cognitive and emotional patterns.
In fact, in ALS patients, higher prevalence of PHOB
personality style, even if not statistically significant, suggests
the presence of alexitimic traits typical of phobic organization,
consisting of a difficulty in identify emotional experiences and to
relate emotional states to somatic perturbations. Such findings
are supported by recent literature highlighting disorders of
emotional processing in ALS patients (Sedda, 2014). Moreover,
these alterations are further supported by neuroimaging and
physiological data (Lulé et al., 2005, 2007; Crespi et al., 2014).
Probably, a change in basic emotional experience in ALS, with
an altered pattern of physiological and behavioral activation
toward positive and negative stimuli, could explain the emotional
adjustment observed in ALS patients, possibly representing a
protective factor against the psychological impact of disability
progression.
Nevertheless, such observations could be further interpreted
according to cognitive and behavioral changes largely identified
in ALS patients (Goldstein and Abrahams, 2013), and to a
possible decreased awareness of such changes (lack of insight);
the latter should be considered as a further, even if less
investigated, feature of the disease (Woolley et al., 2010; Flaherty-
Craig et al., 2011).
The significant compliance to medical treatment and
personality features often observed in ALS patients could likely
arise from the above depicted aspects. Our findings, identifying
a higher prevalence of PHOB personality style in ALS, are
consistent with Brown and Mueller description (Brown and
Mueller, 1970) about patients’ reaction to disease, reporting an
autonomous, hard-working behavioral style of active mastery,
the use of denial coping, and a tendency to use emotional control
to exclude the experience of negative affect from awareness.
In both PH and MS patients, even if the PMO profile
more present is represented by PHOB personality style, when
compared to controls they show significantly higher values for
ED and DEP personality features. Despite such findings, ED and
DEP personality traits do not fulfill the completeness necessary to
identify a different PMO for such neurological conditions.
Concerning MS population, it’s worth to underline
that previous studies mainly focused on the association
between specific personality features and presence/severity of
psychological and somatic disorders, instead of investigating
specific personality profiles characterizing such population;
moreover, heterogeneous instruments have been used for such
purpose. Finally, a possible confounding effect of the emotional
adjustment to the disease when measuring psychological
aspects of patients should be taken into account. Thus, further
investigation of personality aspects in MS population is needed
in order to collect more informative data.
Concerning PH patients, higher values observed in ED traits
are in line with previous description of psychological and
personality aspects highlighting the presence of an analytic
cognitive style in such population (Buonfiglio and Di Sabato,
2011), as could be expected in those persons that tend to be
more consciously aware of the evaluative processes generating an
emotion, instead of more ‘basic emotions’ (Arciero et al., 2004).
To summarize, our data concerning the above-mentioned
conditions do not clearly support disease specific personality
styles both for MS and PH, even if the presence of higher values in
ED and DEP PMOs suggests the need for further investigations.
The higher prevalence of PHOB personality in the overall
sample is in accordance with Guidano’s considerations (Guidano,
1987) about distribution of PMO, showing PHOB one as the most
common.
Correlation analysis concerning relationships between
PMQ and other questionnaires in the control sample partly
support Guidano’s PMO (Guidano, 1987) description and
characterization, especially when ED, DEP and PHOB PMOs
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are considered. The lack of correlational data between Guidano’s
OBS PMO and the assessment tools administered arise
concerning about such PMO characterization when detected with
PMQ.
The above-mentioned considerations can be extended
to correlational data concerning PMQ results and the
other administered questionnaires in neurological conditions
examined, with exception of DEP PMO in ALS and PHOB PMO
in MS. As in controls, no significant correlations were detected
for OBS PMO in all clinical groups considered.
An interesting finding refers to the construct of Guidano’s
PMOs. Accordingly, to what is recorded in clinical practice,
where a continuum between normality and pathology is usually
observed, the distribution of personality styles across the
neurological conditions involved seem to be only exacerbated,
and not modified by the occurrence of the disease. Therefore,
neurological disease seems to modify the consistency of the
observed profile, instead of modifying the prevalence of different
PMOs across diseases.
Even if presented results highlight interesting data, they
cannot be considered conclusive nor exhaustive with regard to
personality stiles in the three neurological groups considered.
A deeper analysis of PMQ usability should include larger
samples of neurological patients, as well as the comparison with
other personality assessment tools and some methodological
adjustments aimed to improve PMQ validity and sensitivity.
Furthermore, assessing personality profile by means of PMQ, in
comparison to other available personality inventories, allows to
deeply focus on the complexity of the human experience and not
only on specific personality dimensions. Such approach, in our
opinion, could possibly better describe the subjective experience
and consequences of living with a neurological disease, thus
integrating research and clinical perspectives. In fact, despite the
common issue of living with a chronic disabling neurological
disorder, specific differences emerged in our neurological samples
not only with respect to personality profile, but also in relation
to psychological symptoms and quality of life aspects (i.e., PH
patients suffering more than MS and ALS patients on a variet of
psychological measurements).
CONCLUSION
Even if the construct of PMO is useful for clinical
psychotherapy, the assessment of cognitive-emotional
organizations in neurological patients within the frame of
cognitive-constructivist frame needs further experimental
investigations.
In spite of these limitations, the findings reported in
the present study represent the first contribution towards
understanding the personality profiles of patients with
neurological conditions according to the cognitive-constructivist
theory. We suggest that adequately assessing these profiles
in clinical practice may be relevant to plan pharmacological
and/or psychological treatment tailored on each patient’s
characteristics.
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